These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
399 related articles for article (PubMed ID: 31221177)
21. Up-regulated Wnt1-inducible signaling pathway protein 1 correlates with poor prognosis and drug resistance by reducing DNA repair in gastric cancer. Zhang LH; Wang Y; Fan QQ; Liu YK; Li LH; Qi XW; Mao Y; Hua D World J Gastroenterol; 2019 Oct; 25(38):5814-5825. PubMed ID: 31636474 [TBL] [Abstract][Full Text] [Related]
22. The significance of NTR1 expression and its correlation with β-catenin and EGFR in gastric cancer. Zhou Z; Xie J; Cai Y; Yang S; Chen Y; Wu H Diagn Pathol; 2015 Jul; 10():128. PubMed ID: 26215716 [TBL] [Abstract][Full Text] [Related]
23. Clinicopathological and prognostic significance of stromal cell derived factor 2 in the patients with gastric cancer. Wang Y; Zheng M; Du S; Wang P; Zhang T; Zhang X; Zu G BMC Gastroenterol; 2024 Sep; 24(1):325. PubMed ID: 39342109 [TBL] [Abstract][Full Text] [Related]
24. Overexpression of the chemokine receptor CXCR3 and its correlation with favorable prognosis in gastric cancer. Hu M; Li K; Maskey N; Xu Z; Yu F; Peng C; Li Y; Yang G Hum Pathol; 2015 Dec; 46(12):1872-80. PubMed ID: 26434630 [TBL] [Abstract][Full Text] [Related]
25. MiR-1236-3p serves as a new diagnostic and prognostic biomarker for gastric cancer. An JX; Ma ZS; Ma MH; Shao S; Cao FL; Dai DQ Cancer Biomark; 2019; 25(2):127-132. PubMed ID: 31045511 [TBL] [Abstract][Full Text] [Related]
26. Keratin 17 expression correlates with tumor progression and poor prognosis in gastric adenocarcinoma. Ide M; Kato T; Ogata K; Mochiki E; Kuwano H; Oyama T Ann Surg Oncol; 2012 Oct; 19(11):3506-14. PubMed ID: 22695933 [TBL] [Abstract][Full Text] [Related]
27. The Prognostic Significance of c-MET and EGFR Overexpression in Resected Gastric Adenocarcinomas. Paliga A; Marginean H; Tessier-Cloutier B; Purgina B; Jonker D; Marginean EC Am J Clin Oncol; 2017 Dec; 40(6):543-551. PubMed ID: 26125303 [TBL] [Abstract][Full Text] [Related]
28. Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer. Yang C; Wen Y; Li H; Zhang D; Zhang N; Shi X; Jiang B; Ma X; Yang P; Tang H; Peng Z; Yang Y Oncol Rep; 2012 Jan; 27(1):135-42. PubMed ID: 21947329 [TBL] [Abstract][Full Text] [Related]
29. Presence of cancer cells in gastric lavage of gastric cancer patients as an indicator of advanced disease, predictor of tumour aggressive phenotype and independent prognostic factor for poor survival: The endoluminal metastatic pathway of gastric cancer and GL0/GL1 classification. Virgilio E; Giarnieri E; Giovagnoli MR; Montagnini M; Proietti A; D'Urso R; Nigri G; Mercantini P; Ramacciato G; Cavallini M; Balducci G Cytopathology; 2018 Feb; 29(1):41-48. PubMed ID: 29063636 [TBL] [Abstract][Full Text] [Related]
30. Clinical Significance of Myeloid Zinc Finger 1 Expression in the Progression of Gastric Tumourigenesis. Li GQ; He Q; Yang L; Wang SB; Yu DD; He YQ; Hu J; Pan YM; Wu Y Cell Physiol Biochem; 2017; 44(3):1242-1250. PubMed ID: 29179204 [TBL] [Abstract][Full Text] [Related]
31. Circulating SHIP2 mRNA as a novel biomarker in the diagnosis and prognosis of gastric cancer. Xie JF; Xie NS; Tang JH; Gu QP; Luo QT Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5129-5134. PubMed ID: 29228424 [TBL] [Abstract][Full Text] [Related]
32. Low expression of MAP1LC3B, associated with low Beclin-1, predicts lymph node metastasis and poor prognosis of gastric cancer. Yu S; Li G; Wang Z; Wang Z; Chen C; Cai S; He Y Tumour Biol; 2016 Nov; 37(11):15007-15017. PubMed ID: 27655288 [TBL] [Abstract][Full Text] [Related]
33. Low CA II expression is associated with tumor aggressiveness and poor prognosis in gastric cancer patients. Hu X; Huang Z; Liao Z; He C; Fang X Int J Clin Exp Pathol; 2014; 7(10):6716-24. PubMed ID: 25400751 [TBL] [Abstract][Full Text] [Related]
34. RAD51B as a potential biomarker for early detection and poor prognostic evaluation contributes to tumorigenesis of gastric cancer. Cheng Y; Yang B; Xi Y; Chen X Tumour Biol; 2016 Nov; 37(11):14969-14978. PubMed ID: 27651161 [TBL] [Abstract][Full Text] [Related]
35. High TREM2 expression correlates with poor prognosis in gastric cancer. Zhang X; Wang W; Li P; Wang X; Ni K Hum Pathol; 2018 Feb; 72():91-99. PubMed ID: 29104108 [TBL] [Abstract][Full Text] [Related]
36. Overexpression of twist and matrix metalloproteinase-9 with metastasis and prognosis in gastric cancer. Gao XH; Yang XQ; Wang BC; Liu SP; Wang FB Asian Pac J Cancer Prev; 2013; 14(9):5055-60. PubMed ID: 24175775 [TBL] [Abstract][Full Text] [Related]
37. ATAD2 is overexpressed in gastric cancer and serves as an independent poor prognostic biomarker. Zhang M; Zhang C; Du W; Yang X; Chen Z Clin Transl Oncol; 2016 Aug; 18(8):776-81. PubMed ID: 26527032 [TBL] [Abstract][Full Text] [Related]
38. Elevated spondin-2 expression correlates with progression and prognosis in gastric cancer. Jin C; Lin JR; Ma L; Song Y; Shi YX; Jiang P; Dong Y; Li XS Oncotarget; 2017 Feb; 8(6):10416-10424. PubMed ID: 28060752 [TBL] [Abstract][Full Text] [Related]
39. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer. Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144 [TBL] [Abstract][Full Text] [Related]
40. Expression of CRM1 and CDK5 shows high prognostic accuracy for gastric cancer. Sun YQ; Xie JW; Xie HT; Chen PC; Zhang XL; Zheng CH; Li P; Wang JB; Lin JX; Cao LL; Huang CM; Lin Y World J Gastroenterol; 2017 Mar; 23(11):2012-2022. PubMed ID: 28373767 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]